Dr. Fong Discusses Intratumoral Electroporation of Plasmid IL-12 in Melanoma
June 2nd 2014Lawrence Fong, MD, from the University of California, San Francisco, discusses the systemic antitumor effect and clinical response in a phase II trial of intratumoral electroporation of plasmid interleukin-12 in patients with advanced melanoma.
Read More